[1]
R. M. Procyshyn, J. W. Lamoure, M. A. Katzman, P. L. Skinner, and S. E. Sherman, “Need for Bioequivalence Standards that Reflect the Clinical Importance of the Complex Pharmacokinetics of Paliperidone Palmitate Long-Acting Injectable Suspension”, J Pharm Pharm Sci, vol. 22, no. 1, pp. 548–566, Jan. 2020.